Regulatory News
Wednesday, November 16, 2016
BRIEF-Cumberland Pharmaceuticals acquires U.S. rights to Nordic Group's methotrexate injection products
* Says it will register and commercialize methotrexate
products in United States
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment